It seems that the reason for this considerably high insulin sensitivity is subcutaneous fat–dominant obesity with reduced visceral fat, higher plasma ghrelin and adiponectin levels, reduced β-cell response to glucose stimulation, and insufficient growth hormone [23–26]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.